J. Shinoda et al., MECHANISM OF ANGIOTENSIN-II-INDUCED ARACHIDONIC-ACID METABOLITE RELEASE IN AORTIC SMOOTH-MUSCLE CELLS - INVOLVEMENT OF PHOSPHOLIPASE-D, European journal of endocrinology, 136(2), 1997, pp. 207-212
In a previous study, we have shown that angiotensin IT (Ang II) activa
tes phosphatidylcholinehydrolyzing phospholipase D due to Ang II-induc
ed Ca2+ influx from extracellular space in subcultured rat aortic smoo
th muscle cells, In the present study, we have investigated the role o
f phospholipase D in Ang II-induced arachidonic acid (AA) metabolite r
elease and prostacyclin synthesis in subcultured rat aortic smooth mus
cle cells. Ang II significantly stimulated Aii metabolite release in a
concentration-dependent manner in the range between 1 nmol/l and 0.1
mu mol/l. D.L-Propranolol hydrochloride (propranolol), an inhibitor of
phosphatidic acid phosphohydrolase, significantly inhibited the Ang I
I-induced release of AA metabolites. The Ang II-induced AA metabolite
release was reduced by chelating extracellular Ca2+ with EGTA. Geniste
in, an inhibitor of protein tyrosine kinases, significantly suppressed
the Ang II-induced AA metabolite release. 1,6-Bis-(cyclohexyloximinoc
arbonylamino)-hexane (RHC-80267), a potent and selective inhibitor of
diacylglycerol lipase, significantly inhibited the Ang II-induced AA m
etabolite release. Both propranolol and RHC-80267 inhibited the Ang II
-induced synthesis of 6-keto-prostaglandin F-1 alpha, a stable metabol
ite of prostacyclin. The synthesis was suppressed by genistein. These
results strongly suggest that the AA metabolite release induced by Ang
IT is mediated, at least in part, through phosphatidylcholine hydroly
sis by phospholipase D activation in aortic smooth muscle cells.